Evommune, Inc. (EVMN)

Evommune Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	0.00	0.00	-0.02
Debt / EBITDA Ratio	0.00	-0.01	-0.03
Debt / FCF Ratio	0.00	-0.01	-0.04
Quick Ratio	8.60	2.57	11.53
Return on Equity (ROE)	37.82%	46.32%	43.82%
Return on Assets (ROA)	-	-87.84%	-41.40%
Return on Capital (ROIC)	44.40%	48.70%	49.50%
Return on Capital Employed (ROCE)	679.99%	-148.83%	-50.28%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).